Cascade Prodrug is dedicated to furthering the development of its proprietary hypoxia-activated switch technology to improve the therapeutic options for patients with solid tumor indications.

Biotechnology

Cascade Prodrug

Cascade Prodrug's headquarters in Portland, OR, United States

August J. Sick

David Regan

John Nepute

Allan Cochrane

Eric Malek

Christopher Klemm

Adam Alani

Thomas K. Wuest

John Keana

Armen B. Shanafelt

Michael Taylor

The Corporate Strategy Team at Cascade Prodrug focuses on shaping the company's long-term vision and strategic initiatives related to its hypoxia-activated switch technology. They assess market opportunities, foster partnerships, and drive business development efforts to enhance therapeutic options for patients with solid tumors. Leveraging their industry expertise, the team ensures alignment between corporate goals and operational execution while navigating the complexities of the biopharmaceutical landscape.

Corporate Strategy Team

The Leadership Team at Cascade Prodrug plays a pivotal role in guiding the strategic direction of the company and overseeing key operations. Comprising co-founders and executives with expertise in corporate development and finance, the team focuses on advancing hypoxia-activated switch technology, fostering partnerships, securing funding, and driving innovation to enhance therapeutic options for patients with solid tumors.

Cascade Prodrug

Org chart

Board & advisors

Teams

Corporate Strategy Team

Leadership Team

Offices

Cascade Prodrug

Org chart

Board & advisors

Teams

Corporate Strategy Team

Leadership Team

Offices

Related companies